BRIEF-Shanton Pharma Receives EMA And FDA Pediatric Study Waivers For SAP-001 In Hyperuricemia

1

Nov 11 (Reuters) – * SHANTON PHARMA RECEIVES EMA AND FDA PEDIATRIC STUDY WAIVERS FOR SAP-001 IN HYPERURICEMIA Source text:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)